|
1 Fishman SJ, Mulliken JB. Hemangiomas and vascular malformations of infancy and childhood. Pediatric Clin North Am, 1993,40:1177-1200.
|
|
2 Mulliken JB, Young AE. Vascular birthmarks：hemangiomas and malformations. Philadelphia:Saunders，1988. 41-103.
|
|
3 Takahashi K, Mulliken JB, Kozakewich HPW, et al. Cellular markers that distinguish the phases of hemangioma during Infancy and childhood. J Clin Invest, 1994,93：2357-2364.
|
|
4 Mulliken JB, Glowacki J. Hemangioma and vascular malformations in infants and children：a classification based on endothelial characteristics. Plast Reconstr Surg,1982,69(3):412-422.
|
|
5 Powell J. Update on hemangiomas and vascular malfoormations. Curr Opin Pediatr,1999,11(5)：457-463.
|
|
6 Mueller BU，Mulliken JB. The infant with a vascular tumor. Semi Perinatol,1999,23(4)：332-340.
|
|
7 Chang J，Most D，Bresnick B，et al. Proliferative hemangioma：analysis of cytokine gene expression and angiogenesis. Plast Reconstr Surg,1999,103(1)：1.
|
|
8 Brouillard P，Vikkula M. Vascular malformations：localized defects in vascular morphogenesis. Clin Genetics，2003 ; 63(5)：340-351.
|
|
9 Sasaki GH，Pang CY，Wittliff JL. Pathogensis and treatment of infant skin strawberry hemangiomas：clinical and in vitro studies of hormoral effects. Plast Reconst Surg, 1984，73：359.
|
|
10 Xiao X,Hong L，Sheng M. Promoting effect of estrogen on the proliferation of hemangioma vascular endothelial cells in vitro. J Pediatr Surg,1999,34(11)：1603-1605.
|
|
11 Rimo L，Roca C，Ferrandi C，et al. Human endothelial cells expressing polyoma middle T induce tumors. Oncogene，2000，19: 3632-3641.
|
|
12 Smoller BR, Chang PP, Kamel OW. No role for human herpes virus 8 in the etiology of infantile capillary hemangioma. Mod Pathol, 1997,10(7)：675.
|
|
13 吴宝成，张红星.人和动物的多瘤病毒.广西科学，1997，4(1)，74-79.
|
|
14 Takahashi K,Mulliken JB,kozakewich HP,et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest,1994，93(6):2357-2364.
|
|
15 Ying Yu，Alan F, Mulliken JB, et al. Endothelial progenitor cells ininfantile hemangioma. Blood, 2004,103：1373-1137.
|
|
16 Peng Q, Liu W，Tang Y, et al. The establishment of the hemangioma model in nude mouse. J Pediatr Surg, 2005, 40(7)：1167-1172.
|
|
17 俞松，刘文英，唐耘熳等.糖皮质激素治疗血管瘤的实验研究.中华医学杂志，2005,85(16): 1121-1124.
|
|
18 Boye E, Yu Y, Paranya G，et al. Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest，2001，107: 745-752.
|
|
19 Gehring U. Glucocorticoid receptors：basis for t he diverse clinical actions of glucocorticoids. Medizinische Klinik，2004，99(5): 228-235.
|
|
20 Kurihara I，Shibata H，Suzuki T, et al. Transcriptional regulation of steroid receptor coactiator-1 in glucocorticoid action. Endocr Res, 2000,26(4)：1033-1038.
|
|
21 刘文英，张尚福，胡廷泽等.小儿血管瘤与血管畸形组织中性激素受体的表达.中华外科杂志，1999，37(5):295-297.
|
|
22 Boon LM, MacDonald DM, MullikenJB. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg, 1999，104:1616.
|
|
23 Liekens S, Verbeken E, Vandeputte M, et al. A novel animal model for hemangiomas：inhibition of hemangioma development by the angiogenesis inhibitor TNP-470. Cancer Res, 1999，59(10):2376-2383.
|
|
24 Ramakrishnan S, Olson TA, Bautch VL, et al. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo. Cancer Res, 1996, 56(6)：1324-1330.
|